Armistice Capital »

Charles River Laboratories shares owned by Armistice Capital

Quarter-by-quarter ownership of Charles River Laboratories (CRL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Charles River Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Charles River Laboratories held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Charles River Laboratories by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $302k 1.9k 156.46
2024-06-30 $25M 119k 206.58
2024-03-31 $19M 70k 270.95
2023-09-30 $31M 156k 195.98

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Charles River Laboratories

Vanguard Group
BlackRock
Wellington Management Company
Allspring Global Investments Holdings
State Street Corporation
Ariel Investments
Harris Associates L.P
Geode Capital Management
Invesco
Dimensional Fund Advisors
Earnest Partners
Mackenzie Financial
D. E. Shaw & Co
National Bank Of Canada /fi/
Neuberger Berman Group

View all funds holding Charles River Laboratories